SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024495
Filing Date
2020-05-12
Accepted
2020-05-12 07:51:34
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-10q_20200331.htm 10-Q 1242478
2 EX-31.1 grtx-ex311_6.htm EX-31.1 18115
3 EX-31.2 grtx-ex312_7.htm EX-31.2 19306
4 EX-32.1 grtx-ex321_8.htm EX-32.1 8464
5 EX-32.2 grtx-ex322_9.htm EX-32.2 8269
  Complete submission text file 0001564590-20-024495.txt   4291281

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT grtx-20200331.xml EX-101.INS 790979
7 XBRL TAXONOMY EXTENSION SCHEMA grtx-20200331.xsd EX-101.SCH 38165
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grtx-20200331_cal.xml EX-101.CAL 39824
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grtx-20200331_def.xml EX-101.DEF 89617
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20200331_lab.xml EX-101.LAB 300942
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20200331_pre.xml EX-101.PRE 219768
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 20867074
SIC: 2834 Pharmaceutical Preparations